Clario Executive and Leadership Team

October, 2026

Leadership Overview

Clario has 9 executives leading key functions including strategy, operations, revenue, medical oversight, legal, and information technology.

Focused on advancing clinical trial technology, Clario delivers comprehensive endpoint solutions that empower pharmaceutical and medical device partners to generate high-quality evidence across global decentralized, hybrid, and site-based research models.

Leadership Roles at Clario

  • Chief Executive Officer & Founder - Joshua Collins
  • President & Chief Executive Officer - Nate Goldenman
  • Chief Operating Officer - Nayan Nanavati
  • Chief Operating Officer & Senior VP - Angelo Stortini
  • Senior Commercial Director - Strategic Chief Revenue Officer Partnerships - Matthew Borer
  • Chief Medical Officer - Todd Rudo
  • Executive Vice President & Chief Legal Officer - Eric Schwartz
  • Vice President and Deputy Chief Medical Officer, Cardiology - Fabian Chen
  • Information - Gary Zimmer
  • Joshua Collins - Chief Executive Officer & Founder

    Joshua Collins, the Chief Executive Officer & Founder at Clario, directs the overarching vision and strategic trajectory of the organization. By architecting the foundational mission to fuse scientific expertise with advanced endpoint technology, Collins ensures the company maintains a competitive edge in the global clinical trial market. This leadership role involves constant engagement with the Board to align long-term growth objectives with the evolving needs of pharmaceutical and biotechnology partners. Joshua Collins drives the development of the Trial Anywhere approach, facilitating seamless data collection across diverse trial models. Through rigorous oversight of corporate culture and innovation, the Chief Executive Officer & Founder fosters an environment dedicated to transforming lives. Ultimately, Collins secures the company's position as a premier provider of clinical evidence, ensuring that every technological advancement supports the broader goal of accelerating regulatory approvals and improving patient outcomes worldwide.

    Nate Goldenman - President & Chief Executive Officer

    Nate Goldenman, the President & Chief Executive Officer at Clario, executes the daily operational strategy and manages the company's expansive global footprint. Overseeing the integration of technology and science, Goldenman ensures that the organization delivers high-quality clinical evidence across North America, Europe, and the Asia Pacific region. This leadership role requires constant collaboration with executive peers to optimize the delivery of endpoint technology solutions for complex clinical trials. Nate Goldenman drives the expansion of market reach by refining the company's service models to meet the specific demands of medical device and biotech partners. By prioritizing operational excellence and scalability, the President & Chief Executive Officer maintains the company's reputation for reliability in high-stakes research environments. Ultimately, Goldenman secures the financial and operational health of the enterprise, ensuring that all internal processes align with the mission of supporting successful regulatory submissions and patient-centric trial experiences.
    Nate Goldenman

    Nayan Nanavati - Chief Operating Officer

    Nayan Nanavati, the Chief Operating Officer at Clario, directs the internal scaling and infrastructure necessary to support global clinical trial operations. Focusing on the efficiency of the endpoint technology platform, Nanavati optimizes the workflows that enable pharmaceutical partners to manage decentralized and hybrid trial models effectively. This leadership role involves streamlining cross-functional processes to ensure that scientific expertise translates into actionable clinical evidence. Nayan Nanavati drives the implementation of robust operational frameworks that support the company's growth across international markets. By managing the intersection of technology deployment and service delivery, the Chief Operating Officer ensures that all project milestones meet rigorous quality standards. Through constant monitoring of operational metrics, Nanavati maintains the agility required to adapt to the fast-paced nature of clinical research. Ultimately, the Chief Operating Officer secures the operational foundation that allows the company to deliver consistent, high-quality results for every client engagement.

    Angelo Stortini - Chief Operating Officer & Senior VP

    Angelo Stortini, the Chief Operating Officer & Senior VP at Clario, directs the supply chain logistics and resource allocation required for complex clinical trial execution. Focusing on the physical and digital infrastructure of site-based trials, Stortini ensures that all necessary technology and equipment reach research sites with precision and reliability. This leadership role involves managing the operational complexities of global logistics to support the company's diverse trial models. Angelo Stortini drives the optimization of site-level support services, ensuring that investigators have the tools needed to generate accurate clinical evidence. By collaborating with technology teams, the Chief Operating Officer & Senior VP maintains the integrity of the endpoint platform across all geographic regions. Through rigorous management of operational assets, Stortini supports the company's commitment to high-quality data collection. Ultimately, the Chief Operating Officer & Senior VP secures the logistical backbone that enables the company to deliver seamless trial experiences for partners worldwide.

    Matthew Borer - Senior Commercial Director - Strategic Chief Revenue Officer Partnerships

    Matthew Borer, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships at Clario, architects the commercial strategy and manages high-value relationships with key industry partners. Focusing on revenue growth, Borer identifies opportunities to integrate the company's endpoint technology into the portfolios of major pharmaceutical and biotechnology firms. This leadership role involves aligning commercial objectives with the broader corporate mission to ensure sustainable market expansion. Matthew Borer drives the development of strategic alliances that enhance the company's presence in the global clinical trial landscape. By coordinating with the executive team, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships ensures that commercial efforts remain synchronized with technological capabilities and service offerings. Through the cultivation of long-term partnerships, Borer secures a steady pipeline of clinical trial projects. Ultimately, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships optimizes revenue streams while expanding the reach of the company's innovative clinical evidence solutions.

    Todd Rudo - Chief Medical Officer

    Todd Rudo, the Chief Medical Officer at Clario, directs the scientific integrity and medical strategy behind the company's endpoint technology platform. Overseeing the clinical validity of data collection methods, Rudo ensures that all solutions meet the stringent requirements of regulatory bodies and pharmaceutical partners. This leadership role involves providing expert guidance on trial design and medical evidence generation to support successful regulatory approvals. Todd Rudo drives the integration of scientific expertise into the company's technology, ensuring that every tool serves the needs of clinical researchers. By collaborating with the broader executive team, the Chief Medical Officer aligns medical standards with the company's operational goals. Through the continuous evaluation of clinical trends, Rudo maintains the company's position at the forefront of medical innovation. Ultimately, the Chief Medical Officer secures the scientific credibility of the organization, ensuring that all clinical evidence produced is of the highest quality for patient safety and regulatory success.
    Todd Rudo
    Eric Schwartz, the Executive Vice President & Chief Legal Officer at Clario, directs the legal strategy and regulatory compliance framework for the entire organization. Focusing on the protection of intellectual property and the navigation of complex international regulations, Schwartz ensures that the company operates within the legal boundaries of the global clinical trial industry. This leadership role involves managing risk and providing counsel on corporate governance to the Board and executive team. Eric Schwartz drives the development of policies that safeguard the company's endpoint technology and data assets. By overseeing legal operations across North America, Europe, and the Asia Pacific region, the Executive Vice President & Chief Legal Officer maintains the company's commitment to ethical research practices. Through proactive legal management, Schwartz supports the company's growth and stability. Ultimately, the Executive Vice President & Chief Legal Officer secures the legal foundation that allows the company to innovate and deliver critical clinical evidence with confidence.

    Fabian Chen - Vice President and Deputy Chief Medical Officer, Cardiology

    Fabian Chen, the Vice President and Deputy Chief Medical Officer, Cardiology at Clario, directs the specialized medical strategy for cardiovascular clinical trials. Focusing on the unique requirements of cardiac endpoint technology, Chen ensures that the company's solutions provide precise and reliable data for heart-related research. This leadership role involves providing deep clinical expertise to support the development of innovative tools for monitoring and analysis. Fabian Chen drives the integration of cardiology-specific standards into the company's broader endpoint platform, enhancing the quality of evidence for medical device and pharmaceutical partners. By collaborating with the Chief Medical Officer, the Vice President and Deputy Chief Medical Officer, Cardiology aligns specialized medical insights with the company's global operational goals. Through the application of advanced clinical knowledge, Chen supports the company's commitment to excellence in complex research areas. Ultimately, the Vice President and Deputy Chief Medical Officer, Cardiology secures the scientific rigor required for successful cardiovascular clinical trials.

    Gary Zimmer - Information

    Gary Zimmer, the Information at Clario, directs the data architecture and information security protocols that underpin the company's endpoint technology platform. Focusing on the integrity and accessibility of clinical data, Zimmer ensures that the company's digital infrastructure remains secure and compliant with global standards. This leadership role involves managing the technological systems that support decentralized and hybrid trial models, ensuring seamless data flow for pharmaceutical partners. Gary Zimmer drives the implementation of advanced security measures to protect sensitive clinical information. By collaborating with the technology and operations teams, the Information maintains the reliability of the company's digital services. Through the continuous improvement of data management systems, Zimmer supports the company's mission to provide high-quality evidence for regulatory approvals. Ultimately, the Information secures the digital environment that allows the company to transform lives through technology, ensuring that all data remains accurate, secure, and readily available for critical research analysis.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Clario Top Executives and Leadership Team

    Who leads Clario?
    Clario is led by Joshua Collins (Chief Executive Officer & Founder), along with executives such as Nate Goldenman (President & Chief Executive Officer) and Nayan Nanavati (Chief Operating Officer).
    Who is part of Clario’s executive team?
    The executive team of Clario includes leaders such as Joshua Collins (Chief Executive Officer & Founder), Nate Goldenman (President & Chief Executive Officer), Nayan Nanavati (Chief Operating Officer) and other senior executives.
    How many executives does Clario have?
    Clario has 9 executives leading key business areas.
    What roles are included in Clario’s leadership team?
    The leadership team of Clario includes roles such as Chief Executive Officer & Founder, President & Chief Executive Officer, Chief Operating Officer, Chief Operating Officer & Senior VP, Senior Commercial Director - Strategic Chief Revenue Officer Partnerships.